发明公开
EP1674091A1 OPHTHALMIC COMPOSITION FOR TREATING LACRIMAL DISORDERS
有权
OPHTHALMISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON LAKRIMAL-ERKRANKUNGEN
- 专利标题: OPHTHALMIC COMPOSITION FOR TREATING LACRIMAL DISORDERS
- 专利标题(中): OPHTHALMISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON LAKRIMAL-ERKRANKUNGEN
-
申请号: EP04788468.9申请日: 2004-09-30
-
公开(公告)号: EP1674091A1公开(公告)日: 2006-06-28
- 发明人: UMEDA, Yuzuru , NAKASHIMA, Hideo, Ophtecs Corporation , SHIBUYA, Michiko, Ophtecs Corporation , SAITOH, Yasukazu , OKADA, Shoji, Ophtecs Corporation , NAKAMURA, Shigeru, Ophtecs Corporation
- 申请人: Ophtecs Corporation
- 申请人地址: 9-1, Edobori 1-chome, Nishi-ku Osaka-shi, Osaka 550-0002 JP
- 专利权人: Ophtecs Corporation
- 当前专利权人: Ophtecs Corporation
- 当前专利权人地址: 9-1, Edobori 1-chome, Nishi-ku Osaka-shi, Osaka 550-0002 JP
- 代理机构: Cresswell, Thomas Anthony
- 优先权: JP2003346858 20031006
- 国际公布: WO2005032534 20050414
- 主分类号: A61K31/19
- IPC分类号: A61K31/19 ; A61K9/06 ; A61K9/08 ; A61P27/04
摘要:
There are provided an ophthalmic composition that comprises 3-hydroxybutyric acid and/or salts thereof as active ingredients and is used to prevent desiccation of eyes and an ophthalmic composition that is used to treat tear dysfunction. By use of the ophthalmic compositions of the present invention, desiccation of the eyes can be inhibited and tear dysfunction can be treated. Therefore, by use of the compositions, discomforts caused by tear dysfunction, such as desiccation of the eyes, foreign-body sensation, feeling of discomfort on the eyes and eye strain, can be improved. Further, the ophthalmic compositions of the present invention can inhibit diseases caused by tear dysfunction, exemplified by development of dry eye and suspected dry eye which are dysfunctions related to desiccation of the eyes, particularly, development of diseases caused by tear dysfunction without injuries on the keratoconjunctive.
公开/授权文献
- EP1674091B1 OPHTHALMIC COMPOSITION FOR TREATING LACRIMAL DISORDERS 公开/授权日:2014-04-23
信息查询